methyl pyruvate has been researched along with Squamous Cell Carcinoma of Head and Neck in 2 studies
*Squamous Cell Carcinoma of Head and Neck: The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Beck, PJ; Boyer, TL; Caste, T; Costa-Pinheiro, P; Fox, TE; Hickman, A; Jameson, MJ; Kester, M; Raymond, MH; Shaw, JJP; Slamowitz, T; Venner, E | 1 |
Amornphimoltham, P; Ando, T; Chen, Q; Goto, Y; Gutkind, JS; Lippman, SM; Murphy, AN; Tamayo, P; Wang, Z; Wu, VH; Wu, X; Yeerna, H; Zhang, X | 1 |
2 other study(ies) available for methyl pyruvate and Squamous Cell Carcinoma of Head and Neck
Article | Year |
---|---|
Inhibition of Lysosomal Function Mitigates Protective Mitophagy and Augments Ceramide Nanoliposome-Induced Cell Death in Head and Neck Squamous Cell Carcinoma.
Topics: Adenosine Triphosphate; Apoptosis; Autophagy; Cell Death; Cell Line, Tumor; Cell Survival; Ceramides; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Liposomes; Lysosomes; Mitochondria; Mitophagy; Nanoparticles; Oxidative Stress; Pyruvates; Reactive Oxygen Species; Signal Transduction; Squamous Cell Carcinoma of Head and Neck | 2020 |
Metformin Inhibits Progression of Head and Neck Squamous Cell Carcinoma by Acting Directly on Carcinoma-Initiating Cells.
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Electron Transport Complex I; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Metformin; Mice, Nude; Pyruvates; Saccharomyces cerevisiae Proteins; Squamous Cell Carcinoma of Head and Neck; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2019 |